Benzgalantamine
| 製品名 | Benzgalantamine |
|---|---|
| CAS番号 | 224169-27-1 |
| 分子式 | C24H27NO3 |
| 分子量 | 377.48 g/mol |
| 外観 | 白色からオフホワイトの結晶性粉末 |
| 分析(HPLC) | ≥98.0% |
| 乾燥減量 | ≤0.5% |
| 焼失残渣 | ≤0.11 TP3T |
| 重金属 | 10 ppm以下 |
| 溶解度 | Soluble in DMSO, methanol; slightly soluble in water |
| ストレージ | Store at 2-8°C, protected from light and moisture |
| パッケージ | 1 kg, 5 kg, 10 kg in aluminum foil bags or fiber drums |
お困りですか? 弊社チームまでお問い合わせください

同義語: Benzgalantamine, 6-O-Benzylgalanthamine, (4aS,6R,8aS)-6-O-Benzyl-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol
In the evolving landscape of cognitive health, the demand for innovative acetylcholinesterase inhibitors has surged. Benzgalantamine has emerged as a compound of significant interest, particularly in the development of next-generation nootropics and therapeutics targeting neurodegenerative conditions. Its unique structural modification offers potential advantages in modulating cholinergic pathways, making it a focal point for research and product development in the pharmaceutical and nutraceutical sectors.
Benzgalantamine is a synthetic derivative of galanthamine, a natural alkaloid found in plants of the Amaryllidaceae family, such as snowdrop and daffodil. The benzyl group at the 6-O position enhances lipophilicity, potentially improving blood-brain barrier penetration and altering pharmacokinetic profiles. This modification distinguishes it from its parent compound, offering new avenues for formulation and efficacy studies.
LyvBio supplies Benzgalantamine with a purity of ≥98.0% (HPLC), ensuring consistent quality for research and development. Our product is synthesized under strict conditions, with comprehensive documentation to support regulatory and quality requirements. It is available in various quantities to accommodate projects from early-stage screening to pilot-scale production.
Benzgalantamine is a benzyl ether derivative of galanthamine, characterized by the addition of a benzyl group to the oxygen at the 6-position of the galanthamine scaffold. This structural change increases the molecule’s lipophilicity, which may influence its interaction with acetylcholinesterase and its distribution in biological systems. The compound is synthesized through a multi-step process starting from galanthamine, involving protection, benzylation, and deprotection steps. Each batch is controlled for identity, purity, and residual solvents to meet stringent specifications.
As a research chemical, Benzgalantamine is intended for laboratory and pilot-scale use. It is not approved for human consumption, and its handling should follow standard safety protocols for potent compounds. LyvBio provides detailed analytical data, including NMR and mass spectra, to confirm structure and purity.
| パラメータ | 仕様 |
|---|---|
| 分析(HPLC) | ≥98.0% |
| 乾燥減量 | ≤0.5% |
| 重金属 | 10 ppm以下 |
| 焼失残渣 | ≤0.11 TP3T |
| Microbial Limits | Total aerobic count ≤1000 CFU/g, Yeast & Mold ≤100 CFU/g, E. coli absent |
| 残留溶剤 | Meets ICH Q3C guidelines |